• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
              Advocacy & Research for Unlimited Lifespans

- - - - -

Professor David A Sinclair: Let’s talk about NMN and NR —The dynamic duo of NAD boosters


  • This topic is locked This topic is locked
No replies to this topic

#1 Fredrik

  • Guest
  • 524 posts
  • 126
  • Location:Stockholm, Sweden
  • NO

Posted 14 July 2019 - 01:27 PM

"...The bottom line, for now, is that the science is a bit further along when it comes to NR, but it is far too early to say which is better for humans. This is not a race. Science isn’t a contest between two competitors. (And there are many other approaches to raising NAD being investigated: other analogs of NMN and NR, CD38 inhibitors, PARP1 inhibitors, SARM1 inhibitors, ACMSD inhibitors, and more.)


Yes, there is rivalry between scientists. It’s usually (although not always) a friendly rivalry.


But ultimately what we do is collaborative. What scientists are learning about NR is helping the researchers in my lab who are focused on NMN and its analogs. What NMN-focused researchers are learning is helping our colleagues understand NR. And the things that all of us are learning are contributing to our understanding of the ultimate goal: treatments and therapies that slow, stop or reverse aging in humans, which treat major diseases of aging, and which are safe and effective at doing so — no matter what they’re called or who invented them."



  • like x 2
  • Informative x 1
  • Cheerful x 1
  • Agree x 1

Also tagged with one or more of these keywords: nmn

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users